SNDY News Alert Solos Endoscopy Inc (SNDY) 0.0005 09/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Solos Endoscopy Inc (SNDY) 0.0005 $SNDY

Solos Endoscopy Files for Medical Device License to Distribute its Endoscopic Instruments in Canada
ACCESSWIRE - Tue Sep 16, 9:42AM CDT
BOSTON, MA / ACCESSWIRE / September 16, 2014 / Solos Endoscopy, Inc. (OTC PINK: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has completed its filing for the Canadian Medical Device License, which will allow Solos to sell certain endoscopic instruments, including the MammoView(R) devices, in Canada.

Solos Endoscopy Reports Financial Results for Period Ended June 30, 2014
ACCESSWIRE - Mon Aug 18, 11:00AM CDT
BOSTON, MA / ACCESSWIRE / August 18, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the United States, reported sales and earnings results for period ended June 30, 2014, and its quarterly disclosure statement on OTC Markets.com.

Solos Endoscopy Posts Shareholder Update on OTC Markets.com
ACCESSWIRE - Wed Jul 23, 9:23AM CDT
BOSTON, MA / ACCESSWIRE / July 23, 2014 / Solos Endoscopy, Inc. (OTC Pink: SNDY) a provider of quality innovative healthcare instruments to Hospitals across the Country, posted an update for the shareholders on OTC Markets.com.

Solos Endoscopy Reports Financial Results for Period Ended December 31, 2013
Marketwire - Tue Apr 01, 9:05AM CDT
Solos Endoscopy, Inc. (OTC Pink: SNDY) (PINKSHEETS: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, reported sales and earnings results for the period ended December 31, 2013.

Solos Endoscopy to Begin Distribution of Its Endoscopic Instruments in Canada
Marketwire - Thu Feb 20, 10:41AM CST
Solos Endoscopy, Inc. (OTC Pink: SNDY), a provider of quality innovative healthcare instruments to hospitals across the United States, is pleased to announce that the company has commenced negotiations with a Canadian distributor to sell its endoscopic instruments including the MammoView(R) devices in Canada.

Halozyme Announces Positive Opinion From CHMP For European Approval Of Roche's MabThera SC
PR Newswire - Fri Jan 24, 10:32AM CST
Halozyme Therapeutics, Inc. (NASDAQ: HALO) announced today that the EU Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve Roche's subcutaneous (SC) formulation of MabThera® (rituximab) using Halozyme's recombinant human hyaluronidase (rHuPH20) for the treatment of patients with common forms of non-Hodgkin lymphoma (NHL).

Pain Therapeutics - Drugs, Markets and Companies
PR Newswire - Thu Jan 16, 1:00PM CST
Dublin - Research and Markets (http://www.researchandmarkets.com/research/sqmftt/pain_therapeutics) has announced the addition of a new report "Pain Therapeutics - Drugs, Markets and Companies" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

Solos Endoscopy Completes Stage 2 of its ISO 13485 Audit with TUV SUD America
ACCESSWIRE - Thu Aug 22, 8:06AM CDT
BOSTON, MA, August 22, 2013 - (Accesswire) - Solos Endoscopy, Inc. (OTCPink: SNDY) is pleased to announce that TUV SUD America has completed its Stage 2 ISO 13485 Audit with Solos Endoscopy on August 16, 2013. Solos Endoscopy will be certified to ISO 13485:2003, the internationally-recognized standard for quality systems for medical device manufacturers, once it reviews and resolves any corrective actions that were discovered during the final audit.

Solos Endoscopy Reports 2nd Quarter Results
ACCESSWIRE - Wed Aug 14, 11:15AM CDT
Company Posts Financials for Period Ended June 30, 2013, President's Letter to Shareholders

Solos Endoscopy Retains Emergo Group to be the Authorized Representative for the Importation of Solos Instruments into Europe
ACCESSWIRE - Fri Aug 02, 8:06AM CDT
BOSTON, August 2, 2013 - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company has retained Emergo Group to act as the Company's authorized representative in Europe. Emergo Group will provide Solos assistance related to communications with authorities and importation of Solos instruments into Europe.

Solos Endoscopy's MammoView(R) System Offers Women Early Breast Cancer Detection
ACCESSWIRE - Thu Jul 18, 12:01PM CDT
BOSTON, MA, July 18, 2013 - (eTeligis via ACCESSWIRE) - Solos Endoscopy, Inc. (OTC PINK: SNDY) is pleased to announce that the Company's MammoView(R) Breast Endoscopy System can aid in giving women the best prognosis for recovery by detecting breast cancer at an earlier stage than conventional methods (http://www.solosendoscopy.com/ductoscope-sell-sheet-final.pdf).

Solos Endoscopy and TUV SUD America Schedule Stage 2 ISO 13485 Audit for August 16, 2013
PR Newswire - Wed Jun 12, 9:06AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company and TUV SUD America has scheduled its Stage 2 ISO 13485 Audit for August 16, 2013.

Solos Endoscopy Reports Full Year 2012 Results
PR Newswire - Wed May 15, 8:36AM CDT
Solos Endoscopy, Inc. (OTCPK: SNDY), a provider of quality innovative healthcare instruments to Hospitals across the Country, reported sales and earnings results for the full year ended December 31, 2012.

Solos Endoscopy Management Announces Goals for 2013
PR Newswire - Fri Jan 04, 9:16AM CST
Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company plans to continue its progress in 2013 as its management has announced its goals for moving forward in the New Year.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 292

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
PawnMate Boosts Inventory Efficiency for Pawnshops

Updated Category News Views 85

RFID Technology: Breathing New Life into Pawnshops Let's get things rolling with the cold, hard truth that pawnshops aren't exactly what most folks expect when it comes to cutting-edge technology. But times are a-changin', and PawnMate’s RFID Inventory Module is the latest twist in this industry storyline. It's like swapping out a rusty toolbox for a brand-new set of...

Continue Reading
LinkedIn Shines: Brands Face Social Media Slump

Updated Category News Views 77

LinkedIn: The Unsung Hero in Social Platforms In a world where social media seems to be as unpredictable as the stock market, LinkedIn is surprisingly holding the line. According to Vista Social's 2027 report, LinkedIn proudly boasts the highest median engagement rate among brand pages at 5.8%. Now, in the wild west of social media, where reach is getting tougher to snag,...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 56

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Go NYC's Perks: Making Commutes Rewarding in NYC

Updated Category News Views 136

Go NYC's Perks: Turning Commutes into Gains I’ve seen a lot of schemes aimed at getting folks to change their travel habits, but this one from Go NYC caught my attention. These guys are trying to squeeze some extra value out of the daily grind for anyone hoofing it across the Big Apple. A new rewards program named Perks kicks off, offering all kinds of discounts and...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 171

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
Cheyenne Real Estate: Neighborhood Nuances and Choices

Updated Category News Views 156

Unearthing the Hidden Dynamics of Cheyenne's Real Estate You've got this picturesque vision in your head of Cheyenne, Wyoming—a sprawling cowboy town with its wild winds and wide-open spaces. But if you think all those neighborhoods are cut from the same cloth, you've got another thing coming. The real estate scene here is just as varied as the prairies stretching out...

Continue Reading
SGRY Acquisition Under Scrutiny: Fairness Questioned

Updated Category News Views 203

Questions Hover Over SGRY Acquisition Here's a real jaw-dropper for you. Surgery Partners, Inc. (NASDAQ: SGRY) is getting clocks cleaned in a fairness probe over its acquisition terms. If you thought this ride was smooth, think again—Levi & Korsinsky, LLP has put the brakes on any such assumptions, launching an investigation that’s sure to raise some eyebrows. What's...

Continue Reading
NVIDIA Faces Turbulent Storm with CEO Resignation

Updated Category News Views 139

Huang's Unexpected Exit and NVIDIA's Rocky Road Well, talk about drama in Silicon Valley. When executives start stumbling, it's not just some PR nightmare—it's a full-on crisis. NVIDIA's co-founder and CEO Jensen Huang is calling it quits, and not on some smooth, idyllic note. No, this is the kind of exit that investors dread. You’ve got affairs, security concerns,...

Continue Reading

Top 5 Most Recently Viewed Articles

Nord Anglia's Private Schools Shine in 2026 National Rankings

Updated Category News Views 363

Nord Anglia's Schools Excel in National Rankings Nord Anglia schools ranked in the top 0.5 to 2% nationally Nord Anglia Education is proud to announce that its schools across the United States have achieved remarkable positions among the leading private schools nationwide, according to the latest Niche rankings for 2026. Unveiling Exceptional Educational Achievements This...

Continue Reading
Ingevity's Leadership Change: New Interim CEO Appointed

Updated Category News Views 151

Ingevity Announces CEO Transition Ingevity Corporation (NYSE: NGVT) has experienced a significant change in its leadership with John Fortson stepping down as president and chief executive officer. Following his departure, the company has entrusted board director Luis Fernandez-Moreno with the role of interim president and CEO while a search is underway for a permanent...

Continue Reading
Projected Growth of Supply Chain Security Market by 2030

Updated Category News Views 165

Growth Prospects of the Supply Chain Security Market The global Supply Chain Security Market is set for significant growth, projected to reach USD 5.14 billion by 2030, up from USD 2.52 billion in 2024. The expected compound annual growth rate (CAGR) during this period is 12.6%, indicating robust expansion in a field that safeguards vital supply chain operations. Scope...

Continue Reading
KLA Corporation's Impressive Fiscal 2026 Q2 Performance Review

Updated Category News Views 249

KLA Corporation's Fiscal 2026 Quarter Two Results Overview KLA Corporation (NASDAQ: KLAC) has reported robust financial results for the second quarter of fiscal year 2026, significantly surpassing expectations. These results underline the company’s powerful position within the semiconductor manufacturing industry. Financial Highlights Revenue Performance The company's...

Continue Reading
Heidi Hunter Steps Up as Vice Chair at Bavarian Nordic Board

Updated Category News Views 152

Heidi Hunter's New Role at Bavarian Nordic Recently, Bavarian Nordic A/S (Copenhagen: BAVA) announced an exciting development by appointing Heidi Hunter as the new Vice Chair of its Board of Directors. This decision follows the recent elevation of Anne Louise Eberhard to Chair, marking a shift in leadership aimed at steering the company forward in the pharmaceutical...

Continue Reading